AACR
Meta-Analysis Questions FDA Warning on Secondary Cancer Risks With CAR T-Cell Therapies
Researchers analyzed two dozen studies and found similar rates of second primary cancers in patients receiving CAR T-cell and standard therapies.
Agendia's ImPrint Headed for Prospective Validation as Tool for Guiding Breast Cancer Immunotherapy
Premium
Retrospective data in two breast cancer subtypes have shown the test's ability to identify responders to neoadjuvant immunotherapy with chemo.
Transgene, NEC Advancing Head and Neck Cancer Vaccine Based on Encouraging Phase I Remission Rate
At AACR, researchers reported that all 16 patients who received the personalized neoantigen vaccine as an adjuvant therapy remained in remission at follow-up.
AstraZeneca's ATM Inhibitor, Radiation Show Encouraging Signals in Two Early Brain Cancer Trials
Premium
At AACR, researchers suggested AZD1390 could penetrate the brain and promote DNA damage repair in MGMT unmethylated glioblastoma.
Delfi Diagnostics' Liquid Biopsy Technology Shows Promise for Ovarian Cancer Screening
The test combining DNA fragmentomics and protein biomarkers had sensitivity ranging from 72 percent to 100 percent for detection of ovarian cancer, depending on disease stage.